About Nichola Eliovits
Nichola Eliovits is a chief executive officer and director at Rinascera Therapeutics.
Form D filings also name Nichola Eliovits as a director at MaverickX and Phoenix Tailings and an executive officer and director at DermBiont.
Nichola Eliovits first appears on SEC filings in 2019.
Experience
This experience comes from Nichola Eliovits's profile and from SEC filings. For roles taken from filings, the years are when the filings name Nichola Eliovits in the role, so the role may have started earlier or lasted longer.
FH
Fuze Health Current
Board Observer
2025 – Present
Maverick Labs, Inc. Current
Director
2024 – Present · Austin, TX
Supplies specialty chemicals for resource extraction from oilfields and mining operations.
KB
Karbon Business Current
Board Member
2022 – Present
Phoenix Tailings, Inc. Current
Director
2021 – Present · Burlington, MA
Produces rare earth metals and alloys for customers worldwide.
MA
Mendel.ai Current
Board Observer
2021 – Present
OC
Olive Tree Capital Current
Managing Partner
2013 – Present
AP
Alto Pharmacy
Board Member
2018 – 2025
DA
Downstream.ai
Board Member
2017 – 2018
KB
Kaleido Biosciences
Board Observer
2017 – 2018
PI
Popover Games, Inc.
Founder & CEO
2010 – 2012
CG
CPM Group
Associate
2007 – 2009
Key Colleagues at Startups
The people Nichola Eliovits works with at each company, as listed on that company's latest Form D.
Maverick Labs, Inc. · Form D, Jun 16, 2026
JE
Jesse Evans
Chief Operating Officer and director
EH
Eric Herrera
CEO and director
Phoenix Tailings, Inc. · Form D/A, Mar 6, 2026
TV
Thomas Villalon
Chief Technology Officer & Co-Founder, director
Steve Bolze
Director
YK
Yong Kim
Director
Anthony Balladon
Chief Commercial Officer & Co-Founder, director
RG
Ramani Ganesh
Director
Nicholas Myers
Chief Executive Officer & Co-Founder, director
Rinascera Therapeutics, Inc. · Form D, Oct 8, 2025
DermBiont, Inc. · Form D/A, Nov 13, 2024
DY
Daniel Yadegar
Director
SB
Steven Basta
Director
KB
Karl Beutner
Chief Executive Officer and director
MD
Max Dawson
Executive officer
WR
Wilder Ramsey
Director